The company's guidance for its Q2 adjusted EPS to be below the analyst estimate and the expected decrease in organic revenue are likely to negatively impact investor sentiment and the stock price in the short term. Lower than expected earnings and declining revenue growth are typically seen as negative indicators by the market.